# Pfizer Inc. (PFE) — Q4-2016 Earnings Results

**Report date:** 2017-01-31 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/PFE/earnings/Q4-2016

## Post-Earnings Brief

### Headline

Pfizer Misses on EPS, Stock Up 1.34%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.47 | N/A | -5.24% |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a cautious outlook, acknowledging the competitive landscape while focusing on future growth opportunities.

**Key quotes:**

> Management highlighted ongoing challenges in the market.

> They emphasized their commitment to innovation and pipeline development.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Pfizer's earnings report shows a slight miss on EPS, which may raise concerns among investors about profitability. However, the stock rose by 1.34%, likely due to positive sentiment around their ongoing projects and future growth potential. Investors may be encouraged by management's focus on innovation despite the EPS miss.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/PFE/earnings/Q4-2016_